Literature DB >> 8399787

Galactosyl hydroxylysine and deoxypyridinoline: a methodological comparison.

P Bettica1, D J Baylink, L Moro.   

Abstract

Galactosyl hydroxylysine and deoxypyridinoline are at present the most promising markers of bone resorption. Various studies have indeed shown that these two markers discriminate with high accuracy subjects with different rates of bone turnover and that their accuracies and discriminate power are very similar. The aim of this paper is to compare the practicality and the reproducibility of the HPLC galactosyl hydroxylysine and deoxypyridinoline assays. In summary, this review shows that the galactosyl hydroxylysine and deoxypyridinoline HPLC assays differ mainly in the need, in using deoxypyridinoline, for an acid hydrolysis and a preextraction of the urine samples. This implies two major problems for deoxypyridinoline: 1) more time is required due to the cumbersome preanalytical procedures; and 2) a lower reproducibility. Our data, in fact, show that both the intra-assay and inter-assay coefficient of variation of the deoxypyridinoline assay are almost 100% higher than those of the galactosyl hydroxylysine assay.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8399787     DOI: 10.1515/cclm.1993.31.7.459

Source DB:  PubMed          Journal:  Eur J Clin Chem Clin Biochem        ISSN: 0939-4974


  2 in total

Review 1.  Bone biomarker for the clinical assessment of osteoporosis: recent developments and future perspectives.

Authors:  Tsung-Rong Kuo; Chih-Hwa Chen
Journal:  Biomark Res       Date:  2017-05-18

2.  Aberrant binding of mutant HSP47 affects posttranslational modification of type I collagen and leads to osteogenesis imperfecta.

Authors:  Delfien Syx; Yoshihiro Ishikawa; Jan Gebauer; Sergei P Boudko; Brecht Guillemyn; Tim Van Damme; Sanne D'hondt; Sofie Symoens; Sheela Nampoothiri; Douglas B Gould; Ulrich Baumann; Hans Peter Bächinger; Fransiska Malfait
Journal:  PLoS Genet       Date:  2021-02-01       Impact factor: 5.917

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.